<?xml version="1.0" encoding="UTF-8"?>
<p class="p">DAG is a well-known allosteric activator of protein kinase C (PKC). DAG has been shown to activate specific PKC isoforms whose activation were linked with insulin resistance (IR) [
 <xref rid="B34" ref-type="bibr" class="xref">34â€“36</xref>]. Additionally, DAG is also associated with hypertension. DAG containing palmitic acid (16:0) was demonstrated to be genetically correlated in a statistically significant manner with hypertension [
 <xref rid="B37" ref-type="bibr" class="xref">37</xref>]. Hypertension, abnormal blood sugar, and obesity are all closely related to the pathogenesis of atherosclerosis. Therefore, the decrease in DAG18:2/16:1 and DAG16:2/18:0 in 
 <italic class="italic">ru</italic> mice may be involved in its anti-atherosclerosis effect.
</p>
